China Universal Asset Management Co. Ltd. Makes New Investment in Inspire Medical Systems, Inc. (NYSE:INSP)

China Universal Asset Management Co. Ltd. acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,574 shares of the company’s stock, valued at approximately $292,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of INSP. State Street Corp raised its position in Inspire Medical Systems by 78.0% in the 3rd quarter. State Street Corp now owns 1,049,784 shares of the company’s stock worth $221,557,000 after purchasing an additional 459,990 shares during the period. Point72 Asset Management L.P. raised its holdings in shares of Inspire Medical Systems by 954.4% in the third quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company’s stock worth $67,402,000 after buying an additional 289,075 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Inspire Medical Systems by 798.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock worth $56,530,000 after acquiring an additional 238,034 shares during the last quarter. Riverbridge Partners LLC purchased a new position in Inspire Medical Systems during the 4th quarter valued at $26,342,000. Finally, Principal Financial Group Inc. grew its position in Inspire Medical Systems by 3,812.6% in the 3rd quarter. Principal Financial Group Inc. now owns 141,089 shares of the company’s stock valued at $29,777,000 after acquiring an additional 137,483 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 0.4 %

Shares of NYSE:INSP opened at $193.90 on Monday. The company has a market capitalization of $5.81 billion, a PE ratio of 181.22 and a beta of 1.32. Inspire Medical Systems, Inc. has a 12-month low of $123.00 and a 12-month high of $257.40. The business’s fifty day simple moving average is $190.21 and its 200-day simple moving average is $188.66.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. During the same period in the previous year, the company posted ($0.29) earnings per share. The firm’s revenue was up 32.6% on a year-over-year basis. Research analysts predict that Inspire Medical Systems, Inc. will post 1.35 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Robert W. Baird lifted their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. KeyCorp reissued an “overweight” rating and issued a $234.00 price objective (down from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and set a $260.00 price target (up previously from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Wells Fargo & Company increased their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. Finally, Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their target price for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $231.45.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.